We collaborate with existing Canadian life sciences companies in a flexible shared risk/reward model. By working together and providing our expertise, infrastructure and capital, adMare enables life sciences companies to further develop their product pipelines, and successfully advance their business to the next corporate value creation point.
Our Investment Criteria
- Differentiation and competitive advantage of technology
- Quality of the team
- Impact of seed money: getting to a value inflection point
- Scope and strength of IP coverage
- Type of co-investors
- Potential Investment return
Click here to know more about the approximately 20 portfolio companies adMare has helped build.
Click here to learn more about adMare’s Resources to Power Innovation.